Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, originally developed for type 2 diabetes management, has become a cornerstone of modern weight loss therapy due to its ability to suppress appetite and regulate blood sugar. The medication works through a carefully structured dosing schedule that starts low and increases progressively over 16 weeks to allow your body to adapt. Understanding how this titration protocol works is essential for anyone considering semaglutide therapy.
How Semaglutide Weight Loss Dosing Works
Semaglutide for weight loss is administered as a once-weekly subcutaneous injection that follows a stepwise escalation protocol. Unlike many medications with fixed doses, semaglutide is intentionally increased in small increments to help your body adjust and reduce gastrointestinal side effects. The typical titration schedule moves from 0.25 mg in week one through week four, then increases by 0.25 mg every four weeks until reaching a maintenance dose.
The standard maintenance dose for weight loss is 2.4 mg weekly, though some patients achieve optimal results at lower doses like 1.7 mg or 2.0 mg. The goal of gradual dose escalation is to find your therapeutic sweet spot—the dose that produces meaningful weight loss while keeping side effects manageable. This personalized approach recognizes that body composition, metabolism, and individual tolerance vary significantly between patients.
Standard Semaglutide Titration Schedule and Timeline
Week 1–4: Your first injection is 0.25 mg once weekly. This starter dose allows your digestive system and appetite regulation centers to acclimate to the medication without overwhelming your system. Most patients experience mild nausea during this phase, which typically subsides within a few days of each injection.
Week 5–8: The dose increases to 0.5 mg weekly. At this level, appetite suppression becomes more pronounced, and many patients notice their food intake naturally decreases without conscious restriction. The cumulative effect from the previous month continues building your therapeutic response.
Week 9–12: Dosing advances to 1.0 mg per week. This mid-range dose delivers significant appetite control for most patients and is the point where sustained weight loss typically accelerates. Some patients find this dose sufficient and choose to remain at this level with their prescriber's approval.
Dose Adjustments Based on Individual Response
Not every patient progresses through the full titration schedule at the standard four-week intervals. If you experience significant nausea, vomiting, or other side effects, your prescriber may slow the escalation by delaying the next dose increase for an additional two to four weeks. This modified timeline allows your body more time to adapt while maintaining the therapeutic benefits.
Conversely, some patients tolerate the standard schedule exceptionally well and progress smoothly. Individual factors like body weight, liver and kidney function, metabolic rate, and concurrent medications all influence how quickly you can safely increase your dose. This is why working with a healthcare provider who monitors your progress is critical—a one-size-fits-all approach misses the biological reality of individual variation.
Genetic predispositions also play a role in how your body responds to semaglutide. PlexusDx's Precision Peptide Genetic Test examines key variants in genes like GLP1R and GIPR that influence your sensitivity to GLP-1 therapies, helping your prescriber anticipate your response and optimize your dosing strategy from the start.
Semaglutide Dosage and Weight Loss Outcomes
Clinical evidence demonstrates a dose-dependent relationship between semaglutide and weight loss results. Patients receiving 0.5 mg weekly typically lose 3–5% of their baseline body weight over 12 weeks. Those advancing to 1.7 mg see average weight losses of 10–15% by six months, while the 2.4 mg dose produces the most robust results, averaging 15–22% weight loss at one year in landmark trials.
The timing of weight loss also correlates with dose escalation. Most patients notice initial appetite suppression within days of their first injection, but measurable weight reduction typically begins in week three to four as the medication accumulates in your system. By week eight to twelve, the rate of weight loss often becomes apparent, with continued steady progress through month six.
Important to note: weight loss plateaus are normal and expected even at higher doses. After four to six months of steady loss, your body may stabilize at a new weight before additional loss resumes. This is not treatment failure but rather your metabolism adjusting to your new body composition. Continuing the medication through this plateau supports long-term weight maintenance.
PlexusDx Compounded Semaglutide Starting at $149/Month
PlexusDx delivers pharmaceutical-grade compounded semaglutide injections prepared by licensed 503A compounding pharmacies, ensuring purity and consistency matching branded standards. Your monthly subscription includes the complete titration protocol from 0.25 mg through your target maintenance dose, with ongoing access to clinical monitoring and dose adjustments. The flat monthly price of $149 covers your medication regardless of which dose you are using—your dose may need to go up, your price won't.
Unlike insurance-dependent weight loss programs, PlexusDx serves all 50 states with no membership fees, no insurance requirements, and HSA/FSA eligibility. After your first month of treatment, you can add PlexusDx's Precision Peptide Genetic Test for $99 to map your peptide pathways and gain insights into 14 genetic-influenced mechanisms affecting your response to semaglutide therapy. This personalization refines your treatment strategy for maximum results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose on semaglutide?
Average weight loss ranges from 10–15% of body weight at the 1.7 mg dose to 15–22% at the 2.4 mg maintenance dose over one year, depending on diet, exercise, and individual metabolism. Results vary significantly, and some patients lose more or less. PlexusDx's personalized approach helps optimize your dosing for your specific biology.
Can I stay on a lower semaglutide dose if it's working?
Yes. Many patients achieve satisfactory weight loss and appetite control at 1.0 mg or 1.7 mg and choose not to advance to 2.4 mg. Work with your prescriber to determine whether your current dose is meeting your goals or if further escalation would benefit you. The goal is therapeutic efficacy tailored to your needs, not a fixed endpoint.
What happens if I skip a dose or stop semaglutide?
Skipping a single weekly injection does not reverse weight loss, but your appetite suppression diminishes within days. If you stop the medication entirely, appetite typically returns within one to two weeks, and weight regain risk increases without continued healthy habits. Long-term use is often necessary to maintain results.
Is nausea during dose escalation normal, and will it go away?
Mild to moderate nausea affects 20–30% of patients during the first two weeks of treatment and again briefly after dose increases. Nausea typically resolves within three to seven days as your body adapts. Eating smaller, frequent meals and avoiding fatty or acidic foods can help. If nausea is severe or persistent, inform your prescriber about slowing your titration schedule.
How does genetic testing through PlexusDx improve my semaglutide outcome?
PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that directly influence your appetite regulation and weight loss response to semaglutide. Understanding your genetic predispositions allows your prescriber to anticipate your dose tolerance, optimize your titration pace, and predict your likely weight loss range—personalizing your entire treatment protocol for your unique biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Am I So Cold Taking Mounjaro?
Navigating Weight Loss: Can You Take Wegovy If You Have Thyroid Issues?